Activist Investor Northstrive Fund II LP Fully Divests Stake in Bluejay Diagnostics
BJDX has more than doubled off its 52-week low of $1.623 on elevated volume (59× avg).
Summary
Activist investor Northstrive Fund II LP and Braeden Lichti have fully exited their position in Bluejay Diagnostics, marking a significant loss of institutional confidence amidst the company's financial challenges.
Key Events · Ownership and Investor Activity · BJDX
-
Activist Investor Exit
Northstrive Fund II LP and Braeden Lichti have sold all their shares and no longer beneficially own any common stock in Bluejay Diagnostics as of June 2, 2026.
-
Final Amendment to Schedule 13D
This filing serves as the final amendment to their Schedule 13D, indicating a complete divestment and exit from their activist position.
-
Context of Financial Distress
This divestment occurs while Bluejay Diagnostics faces a "going concern" warning and is pursuing a reverse stock split to maintain its Nasdaq listing, highlighting a challenging period for the company.
Analysis · BJDX · Industrial Applications And Services
Activist investor Northstrive Fund II LP and Braeden Lichti, who previously filed a Schedule 13D in March 2026 proposing a strategic initiative, have now completely sold their beneficial ownership in Bluejay Diagnostics. This full divestment by an activist investor, especially given the company's ongoing "going concern" warning and recent efforts to avoid Nasdaq delisting, signals a significant loss of confidence in the company's future prospects.
How filings like this one have moved
In the 30 days to Sep 21, 2026, 34.9% of the 999 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BJDX was trading at $4.09 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $1.62 to $16.68. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.